Caracterización clínica y terapéutica de un muestreo portugués de pacientes con esquizofrenia

May 2011
Actas Espanolas de Psiquiatria;may2011, Vol. 39 Issue 3, p147
Academic Journal
Introduction. The development of Mental Health policies for psychiatric disorders should be driven by a correct knowledge of the socio-demographic, clinical and therapeutic realities of the disease. There is paucity of detailed studies in the Portuguese population that does not allow a direct comparison with other European countries. The objective of the present study is to characterize the sociodemographic and clinical characteristics of schizophrenia patients in Portugal and the therapeutic patterns. Methods. This multicentric, cross sectional, non interventional study was designed to describe the demographic and clinical data of patients with schizophrenia (n=474), and also the demographic and professional characteristics of their treating psychiatrists. Results. The most frequent diagnosis found was paranoid schizophrenia (54%), with comorbid psychiatric conditions in 39,7% and somatic diseases in 28.4% of the patients. About half the patients were on second generation antipsychotics (SGS) as principal therapy, although haloperidol has been the most frequent drug prescribed as so (35.9 %). 59.51 % of the patients were on antipsychotic monotherapy, and 45% on a depot formulation. Antipsychotic dose vary widely, and they are quite often prescribed on off label doses. Discussion. Our sample is similar to others found in naturalistic studies, however slightly different from clinical trials. In general, patients with schizophrenia tend to be treated with SGA, although have a higher chance to be on a long-term formulation and to be on polytherapy than in other studies. Somatic diseases are maybe under diagnosed and are undertreated.


Related Articles

  • Satisfaction of hospitalized psychiatry patients: why should clinicians care? Zendjidjian, Xavier-Yves; Baumstarck, Karine; Auquier, Pascal; Loundou, Anderson; Lancon, Christophe; Boyer, Laurent // Patient Preference & Adherence;2014, Vol. 8, p575 

    Background: The aim of this study was to determine the relationship between inpatient satisfaction and health outcomes, quality of life, and adherence to treatment in a sample of patients with schizophrenia, while considering key sociodemographic and clinical confounding factors. Methods: This...

  • Prevalence and Correlates of Cigarette Smoking among Chinese Schizophrenia Inpatients Receiving Antipsychotic Mono-Therapy. Xu, Yan-Min; Chen, Hong-Hui; Li, Fu; Deng, Fang; Liu, Xiao-Bo; Yang, Hai-Chen; Qi, Li-Guo; Guo, Jin-Hong; Liu, Tie-Bang // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Objective: To investigate the prevalence rate of cigarette smoking and its socio-demographic and clinical correlates in Chinese schizophrenia inpatients receiving antipsychotic mono-therapy. Methods: This study was a cross-sectional, two-site, hospital-based survey. Four hundred and twenty-nine...

  • New class of antipsychotic drugs for schizophrenia. Breier, Alan // Cortlandt Forum;07/25/97, Vol. 10 Issue 7, p23 

    Describes antipsychotic drugs for the treatment of schizophrenia in the United States. Clozapine; Risperidone; Olanzapine; Sertindole; Comparison to haloperidol-like drugs.

  • Relationships between Use of Long Acting Antipsychotics and Sociodemographic and Clinical Characteristics of Patients with Schizophrenia. Albayrak, Yakup; Unsal, Cuneyt; Beyazyuz, Murat // Klinik Psikofarmakoloji Bulteni;2013, Vol. 23 Issue 2, p171 

    Objective: Schizophrenia is a chronic psychiatric disorder that causes severe sociooccupational disability. The primary goal of treatment is to prevent a subsequent relapse and restore sociooccupational functioning to the premorbid level. However, high rates of relapses can be seen during the...

  • Gender differences in coerced patients with schizophrenia. Nawka, Alexander; Kalisova, Lucie; Raboch, Jiri; Giacco, Domenico; Cihal, Libor; Onchev, Georgi; Karastergiou, Anastasia; Solomon, Zahava; Fiorillo, Andrea; Del Vecchio, Valeria; Dembinskas, Algirdas; Kiejna, Andrzej; Nawka, Petr; Torres-Gonzales, Francisco; Priebe, Stefan; Kjellin, Lars; Kallert, Thomas W. // BMC Psychiatry;2013, Vol. 13 Issue 1, p179 

    Background Despite the recent increase of research interest in involuntary treatment and the use of coercive measures, gender differences among coerced schizophrenia patients still remain understudied. It is well recognized that there are gender differences both in biological correlates and...

  • Kronik Hasta Servislerinde Uzun Süre Yatan Åžizofreni Hastaları Nasıl Tedavi Ediliyor? Kurt, Erhan; Özver, ‹smail; Alataş, Gazi; Bilgiç, Vedat // Yeni Symposium;2010, Vol. 48 Issue 3, p223 

    Objective: With this study , the evaluation of their treatment of patients with schizophreniawho have been hospitalized for a long time in the chronic psychiatric patients services in Bakirkoy Research and Training Hospital for Psychiatry, Neurology and Neurosurgery was aimed. Method: The...

  • Åžzofrenide Cinsel Ä°ÅŸlev Bozuklukları: Kesitsel Bir DeÄŸerlendirme. Çakmak, Soner; Karakuş, Gonca; Evlice, Yunus Emre // Klinik Psikiyatri Dergisi;2010, Vol. 13 Issue 2, p55 

    No abstract available.

  • The lifetime outcome and involuntary movements of schizophrenia never treated with neuroleptic drugs. Four rare cases in Ireland. Waddington, John L.; Youssef, Hanafy A.; Waddington, J L; Youssef, H A // British Journal of Psychiatry;Jan90, Vol. 156, p106 

    Four elderly schizophrenic patients who had never been treated with neuroleptics, and a fifth patient who had received only the briefest exposure to such drugs, had retained their distinct clinical characteristics. Involuntary orofacial movements and cognitive dysfunction were found more...

  • Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-Generation Versus Second-Generation Medications. Hartling, Lisa; Abou-Setta, Ahmed M.; Dursun, Serdar; Mousavi, Shima S.; Pasichnyk, Dion; Newton, Amanda S. // Annals of Internal Medicine;10/2/2012, Vol. 157 Issue 7, p498 

    Background: Debate continues about the comparative benefits and harms of first-generation antipsychotics (FCAs) and second-generation antipsychotics (SGAs) in treating schizophrenia. Purpose: To compare the effects of FGAs with those of SGAs in the treatment of adults aged 18 to 64 years with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics